Patient satisfaction and clinical efficacy of the flash glucose monitoring in the patients with type 1 diabetes

Patient satisfaction and clinical efficacy of the flash glucose monitoring in the patients with type 1 diabetes - Patient satisfaction of the FGM in T1D

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029673

Enrollment

Registered

2017-10-25

Start date

2017-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes

Interventions

Patients use the FGM (FreeStyle Libre) for 12weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Type 1 diabetes 2. Age: 18 to 75 years old

Exclusion criteria

Exclusion criteria: 1. Hypersensitivity to medical patches

Design outcomes

Primary

Measure	Time frame
Changes in the DTSQ scores before and 4 weeks after FGM use	—

Countries

Japan

Contacts

Public ContactDaisuke Chujo

National Center for Global Health and Medicine Department of Diabetes, Endocrinology, and Metabolism

dchujo@hosp.ncgm.go.jp03-3202-7181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026